EFMH
RMD icon

E Fund Management (HK)’s ResMed RMD Stock Holding History

E Fund Management (HK)’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.19K Hold
42
– – ﹤0.01% 449
2026
Q1 		$9.43K Buy
42
+41
+4,100% +$10.2K ﹤0.01% 345
2025
Q4 		$255 Hold
1
– – ﹤0.01% 389
2025
Q3 		$274 Buy
+1
New +$273 ﹤0.01% 345

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

E Fund Management (HK)'s RMD Position: Q2 2026 in Review

E Fund Management (HK) held its ResMed (RMD) position steady in Q2 2026 at 42 shares worth $8.19K. The position accounts for ﹤0.01% of the portfolio, ranked #449.

E Fund Management (HK) first reported a position in RMD in Q3 2025 and has held it in 4 quarters since. The position peaked at $9.43K in Q1 2026. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • E Fund Management (HK) held 42 shares of ResMed worth $8.19K as of Q2 2026.
  • E Fund Management (HK) left its ResMed share count unchanged in Q2 2026.
  • ResMed made up ﹤0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #449 holding.
  • E Fund Management (HK) first reported a position in ResMed in Q3 2025 and has held it in 4 quarters since.
  • E Fund Management (HK)'s ResMed position peaked at $9.43K in Q1 2026.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.